» Articles » PMID: 19150911

Health Care Utilization, Barriers to Care, and Hormone Usage Among Male-to-female Transgender Persons in New York City

Overview
Specialty Public Health
Date 2009 Jan 20
PMID 19150911
Citations 177
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: We investigated health care utilization, barriers to care, and hormone use among male-to-female transgender persons residing in New York City to determine whether current care is in accord with the World Professional Association for Transgender Health and the goals of Healthy People 2010.

Methods: We conducted interviews with 101 male-to-female transgender persons from 3 community health centers in 2007.

Results: Most participants reported having health insurance (77%; n = 78) and seeing a general practitioner in the past year (81%; n = 82). Over 25% of participants perceived the cost of medical care, access to specialists, and a paucity of transgender-friendly and transgender-knowledgeable providers as barriers to care. Being under a physician's care was associated with high-risk behavior reduction, including smoking cessation (P = .004) and obtaining needles from a licensed physician (P = .002). Male-to-female transgender persons under a physician's care were more likely to obtain hormone therapies from a licensed physician (P < .001).

Conclusions: Utilization of health care providers by male-to-female transgender persons is associated with their reduction of some high-risk behaviors, but it does not result in adherence to standard of care recommendations for transgender individuals.

Citing Articles

Hormonal stories: a new materialist exploration of hormonal emplotment in four case studies.

Erikainen S, Ford A, Malcolm R, Raeder L Biosocieties. 2025; 20(1):1-24.

PMID: 40060941 PMC: 11885154. DOI: 10.1057/s41292-023-00317-8.


Inclusivity in Epilepsy Care: Navigating the Complex Nature of Seizure Disorders in People Undergoing Gender-Affirming Care.

Alick-Lindstrom S, Weingarten M, Falco-Walter J, Gidal B, Abramowitz J, Lane C Epilepsy Curr. 2025; :15357597251317908.

PMID: 40040857 PMC: 11873854. DOI: 10.1177/15357597251317908.


Exploring the Lived Experience of Elderly Transgender People: Qualitative Phenomenological Study.

Thelly A, Manivasakan S, Kripa A, Sheethal K Indian J Palliat Care. 2025; 31(1):27-31.

PMID: 40027981 PMC: 11866657. DOI: 10.25259/IJPC_130_2024.


Understanding the context of positive experiences of primary care for transgender and gender diverse adults: An email interview study in Aotearoa New Zealand.

Withey-Rila C, Morgaine K, Treharne G Int J Transgend Health. 2024; 25(4):704-718.

PMID: 39465076 PMC: 11500521. DOI: 10.1080/26895269.2023.2234899.


Instruments used to assess gender-affirming healthcare access: A scoping review.

Kearns S, Hardie P, OShea D, Neff K PLoS One. 2024; 19(6):e0298821.

PMID: 38829881 PMC: 11146745. DOI: 10.1371/journal.pone.0298821.


References
1.
Kenagy G . Transgender health: findings from two needs assessment studies in Philadelphia. Health Soc Work. 2005; 30(1):19-26. DOI: 10.1093/hsw/30.1.19. View

2.
Sanchez N, Rabatin J, Sanchez J, Hubbard S, Kalet A . Medical students' ability to care for lesbian, gay, bisexual, and transgendered patients. Fam Med. 2005; 38(1):21-7. View

3.
Clements-Nolle K, Marx R, Guzman R, Katz M . HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons: implications for public health intervention. Am J Public Health. 2001; 91(6):915-21. PMC: 1446468. DOI: 10.2105/ajph.91.6.915. View

4.
Feldman J, Bockting W . Transgender health. Minn Med. 2003; 86(7):25-32. View

5.
Moore E, Wisniewski A, Dobs A . Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects. J Clin Endocrinol Metab. 2003; 88(8):3467-73. DOI: 10.1210/jc.2002-021967. View